Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK44459 in Behçet's Disease
NCT06902428Phase 2Not yet recruiting
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Mar 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of HSK44459 in Behçet's disease (BD), sponsored by Haisco Pharmaceutical Group Co., Ltd.. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
HSK44459
03
Conditions
Behçet's disease (BD)
Beyond the preview
Go deeper on NCT06902428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06902428.